Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-13

Clinical Trial Update: Oxytocin Treatment of Alcohol Withdrawal [Phase 1]

View source ↗

Summary

Phase 1 study evaluating oxytocin for alcohol withdrawal has completed. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Alcohol Withdrawal | Phase 1 | Status: COMPLETED | Results posted: 2014-05-13